| Background: | Ecalectin, also known as a galectin-9, is a 36 kDa ?-galactoside-binding lectin derived from antigen-stimulated T lymphocytes. Ecalectin is a potent and selective chemoattractant for eosinophils. It has also been shown to induce eosinophil aggregation, stimulate superoxide production and directly prolong eosinophil survival. It is reported that Ecalectin has various biological functions besides eosinophil chemoattractant, such as a regulator of thymocyte-epithelial cell interactions, an apoptosis of human T cells and melanoma cells, and murine thymocytes, as well as a function as a urate channel/transporter and an anti-inflammatory activity in the nephrotoxic serum nephritis model. |
| Clonality: | Monoclonal |
| Clone Number: | ECA42 |
| Formulation: | 1 mg/mL in PBS/50% glycerol, pH 7.2 |
| Gene ID Human: | 3965 |
| Gene ID Mouse: | 16859 |
| Host Species: | Mouse |
| Immunogen: | Recombinant Human Ecalectin |
| Regulatory Statement: | For Research Use Only. Not for use in diagnostic procedures. |
| Isotype: | IgG2b |
| Product Type: | Primary Antibody |
| Shipping: | 4 |
| Size: | 100 μg |
| Species Reactivities: | Human |
| Status: | RUO |
| Storage: | -20℃ |
| Target: | Ecalectin/Galectin-9 |
Applications: ELISA, FCM
| ELISA: | 100 ng/mL (Biotin-conjugated) |
| FCM: | 5 ug/mL (final concentration) |
There are no references for Anti-Ecalectin (Galectin-9) (Human) mAb at this time.

